Support The Moscow Times!

Drugmakers' Stocks Slump

Protek headed for its lowest level in more than a week Friday after the Federal Anti-Monopoly Service said it will investigate charges that the pharmaceutical wholesaler and 17 others companies rigged government drug-supply tenders.

The stock fell as much as 3.1 percent and last traded 2 percent lower at 41.72 rubles as of 12:15 a.m. in Moscow. A close at that price would be its weakest since April 5. The regulator said 18 manufacturers, including Protek and Pharmstandard, are suspected of illegally colluding in tenders in 2008 and 2009.

Pharmstandard fell for a second day, losing 0.8 percent and closing around 2,600 rubles.


Read more

Independent journalism isn’t dead. You can help keep it alive.

As the only remaining independent, English-language news source reporting from Russia, The Moscow Times plays a critical role in connecting Russia to the world.

Editorial decisions are made entirely by journalists in our newsroom, who adhere to the highest ethical standards. We fearlessly cover issues that are often considered off-limits or taboo in Russia, from domestic violence and LGBT issues to the climate crisis and a secretive nuclear blast that exposed unknowing doctors to radiation.

As we approach the holiday season, please consider making a one-time donation — or better still a recurring donation — to The Moscow Times to help us continue producing vital, high-quality journalism about the world’s largest country.